Identification of AIM2 as a downstream target of JAK2V617F

BACKGROUND: The gain-of-function mutation JAK2V617F is frequently found in Philadelphia-chromosome-negative myeloproliferative neoplasm (MPN) patients. However, the tumorigenic properties of JAK2V617F have mostly been characterized in in vivo and in vitro murine models due to the lack of appropriate...

Descripción completa

Detalles Bibliográficos
Autores principales: Liew, Ei Leen, Araki, Marito, Hironaka, Yumi, Mori, Seiichi, Tan, Tuan Zea, Morishita, Soji, Edahiro, Yoko, Ohsaka, Akimichi, Komatsu, Norio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730608/
https://www.ncbi.nlm.nih.gov/pubmed/26823993
http://dx.doi.org/10.1186/s40164-016-0032-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730608/
https://www.ncbi.nlm.nih.gov/pubmed/26823993
http://dx.doi.org/10.1186/s40164-016-0032-7

Ejemplares similares